[GLMD] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[GLMD] Galmed Pharmaceuticals Ltd.
Announcement Date
23-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- -59.60%
Quarter Report
GLMD's Result
GLMD's Financial Summary
View:
Show?
Annual Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 0 2,038 1,085 467 0 0 0 -
PBT -20,461 -9,781 -12,299 -16,847 -10,622 -9,102 -17,484 2.65%
Tax -1,920 75 12,364 106 21,244 1 1 -
NP -18,541 -9,856 -12,299 -16,953 -10,622 -9,103 -17,485 0.98%
Tax Rate - - - - - - - -
Total Cost 18,541 11,894 13,384 17,420 10,622 9,103 17,485 0.98%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin 0.00 -483.61 -1,133.55 -3,630.19 0.00 0.00 0.00 -
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -13.17 -8.15 -14.77 -22.36 -14.35 -13.23 -24.57 -9.86%
EPS Diluted -13.17 -8.15 -14.77 -22.36 -14.35 -13.23 -24.57 -9.86%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.